Page 61 - GPD-2-3
P. 61

Gene & Protein in Disease                                              SARS-CoV-2 Omicron variants in Iraq



            References                                            https://doi.org/10.1111/j.1365-2133.2005.06587.x

            1.   Coronaviridae Study Group of the International Committee   14.  Brüssow H, 2022, COVID-19: Omicron-the latest, the least
               on Taxonomy of Viruses, 2020, The species Severe acute   virulent,  but  probably  not  the  last  variant  of  concern  of
               respiratory syndrome-related coronavirus: Classifying 2019-  SARS-CoV-2. Microb Biotechnol, 15: 1927–1939.
               nCoV and naming it SARS-CoV-2. Nat Microbiol, 5: 536–544.      https://doi.org/10.1111/1751-7915.14064
               https://doi.org/10.1038/s41564-020-0695-z       15.  Lauring AS, Hodcroft E, 2021, Genetic variants of SARS-
            2.   Zhou P, Yang XL, Wang XG,  et al., 2020, A pneumonia   CoV-2-what do they mean? JAMA, 325: 529–531.
               outbreak associated with a new coronavirus of probable bat      https://doi.org/10.1001/jama.2020.27124
               origin. Nature, 579: 270–273.
                                                               16.  Ledford H, 2021, How severe are Omicron infections.
               https://doi.org/10.1038/s41586-020-2012-7          Nature, 600: 577–578.
            3.   Waris A, Atta UK, Ali M, et al., 2020, COVID-19 outbreak:      https://doi.org/10.1038/d41586-021-03794-8
               Current scenario of Pakistan.  New  Microbes  New  Infect,
               35: 100681.                                     17.  Burki TK, 2022, Omicron variant and booster COVID-19
                                                                  vaccines. Lancet Respir Med, 10: e17.
               https://doi.org/10.1016/j.nmni.2020.100681
                                                                  https://doi.org/10.1016/S2213-2600(21)00559-2
            4.   Waris A, Ali M, Khan AU, et al., 2020, COVID-19 incidence   18.  da Silva SJR, Kohl A, Pena L, et al., 2022, Recent insights into
               in Pakistan: Gender disparity. Iran J Psychiatry Behav Sci, 14:   SARS-CoV-2 omicron variant. Rev Med Virol, 33: e2373.
               e105990.
                                                                  https://doi.org/10.1002/rmv.2373
            5.   World Health Organization, 2023, COVID-19 Weekly
               Epidemiological  Update.  Geneva:  World  Health  19.  Zamel D, Khan AU, 2022, Covid-19 vaccines: Overview,
               Organization.                                      comparative analysis and dynamics. Acta Sci Biotechnol Vol,
                                                                  3: 24–33.
            6.   World Health Organization, 2022, World Health
               Organization  (WHO)   Coronavirus  (COVID-19)   20.  Karim SSA, Karim QA, 2021, Omicron SARS-CoV-2
               Dashboard. World Health Organization. Available from:   variant: A new chapter in the COVID-19 pandemic. Lancet,
               https://covid19who.int [Last accessed on 2022 Feb 28].  398: 2126–2128.
            7.   Alsayed R, Ali A, Makia R, et al., 2020, Challenges facing      https://doi.org/10.1016/S0140-6736(21)02758-6
               Iraq to tackle the spread of COVID-19: An overview. J Univ   21.  Sun J, Xie T, Jamal M, et al., 2020, CLEC3B as a potential
               Anbar Pure Sci, 14: 22–27.                         diagnostic and prognostic biomarker in lung cancer and
            8.   Fayad N, Abi Habib W, Kandeil A, et al., 2021, SARS-CoV-2   association with the immune microenvironment.  Cancer
               variants in Lebanon: Evolution and current situation.   Cell Int, 20: 106.
               Biology (Basel), 10: 531.                          https://doi.org/10.1186/s12935-020-01183-1
               https://doi.org/10.3390/biology10060531         22.  Hulo C, de Castro E, Masson P,  et al., 2011, ViralZone:
            9.   Kim D, Lee JY, Yang JS,  et al., 2020, The architecture of   A knowledge resource to understand virus diversity. Nucleic
               SARS-CoV-2 transcriptome. Cell, 181: 914–921.e10.  Acids Res, 39: D576–D582.
               https://doi.org/10.1016/j.cell.2020.04.011         https://doi.org/10.1093/nar/gkq901
            10.  Wang R, Hozumi Y, Yin C,  et al., 2020, Mutations on   23.  Hadfield J, Megill C, Bell SM,  et al., 2018, Nextstrain:
               COVID-19 diagnostic targets. Genomics, 112: 5204–5213.  Real-time  tracking  of  pathogen  evolution.  Bioinformatics,
                                                                  34: 4121–4123.
               https://doi.org/10.1016/j.ygeno.2020.09.028
                                                                  https://doi.org/10.1093/bioinformatics/bty407
            11.  Sabir  DK,  2022,  Analysis  of  SARS-COV2  spike  protein
               variants among Iraqi isolates. Gene Rep, 26: 101420.  24.  Worldometers.info.  Available  from:  https://www.
                                                                  worldometers.info/coronavirus/country/iraq [Last accessed
               https://doi.org/10.1016/j.genrep.2021.101420       on 2023 May 31].
            12.  Yang  H, Rao Z,  2021,  Structural biology of  SARS-CoV-2   25.  Sabir DK, Khwarahm NR, Ali SM,  et al., 2020, Children
               and implications  for therapeutic  development.  Nat  Rev   protection against COVID-19 at the pandemic outbreak.
               Microbiol, 19: 685–700.                            J Immunol Sci, 4: 8–12.
               https://doi.org/10.1038/s41579-021-00630-8         https://doi.org/10.29245/2578-3009/2020/2.1188
            13.  Tilli CMLJ, Van Steensel MA, Krekels GA,  et al., 2005,   26.  Zhou Y, Zhi H, Teng Y, 2023, The outbreak of SARS-CoV-2
               Molecular aetiology and pathogenesis of basal cell   Omicron lineages, immune escape, and vaccine effectivity.
               carcinoma. Br J Dermatol, 152: 1108–1124.          J Med Virol, 95: e28138.


            Volume 2 Issue 3 (2023)                         8                        https://doi.org/10.36922/gpd.1646
   56   57   58   59   60   61   62   63   64   65   66